BSE Live
Dec 30, 16:01Prev. Close
133.75
Open Price
133.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 16:09Prev. Close
133.62
Open Price
133.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
134.45 (49)
| Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -39.52 | 34.32 | -22.49 | -72.23 | -8.51 | |
| Net CashFlow From Operating Activities | -39.58 | 36.90 | -95.34 | -69.45 | 2.29 | |
| Net Cash Used In Investing Activities | 51.41 | 43.59 | -99.31 | -2.42 | -7.64 | |
| Net Cash Used From Financing Activities | -1.26 | -80.84 | 194.39 | 72.10 | 4.41 | |
| Foreign Exchange Gains / Losses | 0.05 | 0.03 | 0.02 | 0.01 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 10.62 | -0.32 | -0.23 | 0.24 | -0.93 | |
| Cash And Cash Equivalents Begin of Year | 0.01 | 0.33 | 0.57 | 0.34 | 1.27 | |
| Cash And Cash Equivalents End Of Year | 10.63 | 0.01 | 0.34 | 0.57 | 0.34 |
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y